Skip to main content
. 2015 Aug 10;6(30):29296–29310. doi: 10.18632/oncotarget.4828

Figure 2. MTT proliferation assays: WF increases MCF-7 and MDA-MB-231 cell proliferation.

Figure 2

A. and C. The proliferation rates of MCF-7 and MDA-MB-231 cells are significantly increased after treated with WF for 48 hours when compared to the control group. B. and D. No significant difference of proliferation rate is observed between benign disease and breast cancer groups (both MCF-7 and MDA-MB-231 cells). E. MDA-MB-231 cells treated with WF from breast cancer patients underwent neoadjuvant chemotherapy (NAC) show higher rate of proliferation.